GUIDED THERAPEUTIC (GTHP)

0.00
OTC BB
Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.20
Exchange OTC BB
Shares Outstanding 211.29B
Market Cap 802.90K
Div & Yield N.A. (N.A)

Latest News

Guided Therapeutics Achieves Regulatory Approval For Sale In India

Guided Therapeutics Achieves Regulatory Approval For Sale In India

Guided Therapeutics, Inc. (OTCQB: GTHP) reported today that the Company received Regulatory Approval from the Indian Ministry of Health & Family Welfare to allow commercialization of the LuViva device and disposables.

Guided Therapeutics Ships 8 LuViva Devices And 4,500 Single Use Cervical Guides To Indonesia In Q4 2017

Guided Therapeutics Ships 8 LuViva Devices And 4,500 Single Use Cervical Guides To Indonesia In Q4 2017

Guided Therapeutics, Inc. (OTCQB: GTHP) reported today record sales for a quarter in Indonesia, with eight LuViva® Advanced Cervical Scans shipped in the fourth quarter of last year.

Guided Therapeutics Signs Preliminary License Agreement With Turkish Distribution Partner Based On Ministry Of Health Support For The LuViva Advanced Cervical Scan

Guided Therapeutics Signs Preliminary License Agreement With Turkish Distribution Partner Based On Ministry Of Health Support For The LuViva Advanced Cervical Scan

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it has signed a preliminary license agreement with its Turkish...

Guided Therapeutics Continues To Grow International Sales With New Order Of Disposables From Indonesia And Letter Of Intent For Distribution In India

Guided Therapeutics Continues To Grow International Sales With New Order Of Disposables From Indonesia And Letter Of Intent For Distribution In India

Guided Therapeutics, Inc. (OTCQB:GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it has received a new order of 4,000 single-patient-use Cervical...

Guided Therapeutics Re-establishes Communications With U.S. FDA And Discusses Plan For Refiling For Approval Of The LuViva® Advanced Cervical Scan

Guided Therapeutics Re-establishes Communications With U.S. FDA And Discusses Plan For Refiling For Approval Of The LuViva® Advanced Cervical Scan

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it has re-opened discussions with the U.

Guided Therapeutics Receives Order For 10 LuViva® Advanced Cervical Scans For Indonesia

Guided Therapeutics, Inc. (OTCQB: GTHP), developer of the LuViva® Advanced Cervical Scan, a non-invasive device used to detect cervical disease instantly at the point of care, today announced it has received an order...

Guided Therapeutics Ships Five LuViva® Advanced Cervical Scans To Chinese Partner Shandong Yaohua

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it has shipped five LuViva devices and associated disposables to...

Guided Therapeutics Enters Into LuViva® Advanced Cervical Scan Manufacturing And License Agreement For China

Guided Therapeutics Enters Into LuViva® Advanced Cervical Scan Manufacturing And License Agreement For China

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it has reached agreement with Shandong Yaohua Medical Instrument...

CORRECTING and REPLACING Guided Therapeutics Announces 1:800 Reverse Stock Split and Elimination of "Toxic" Convertible Securities from its Balance Sheet

CORRECTING and REPLACING Guided Therapeutics Announces 1:800 Reverse Stock Split and Elimination of "Toxic" Convertible Securities from its Balance Sheet

First paragraph, second sentence of release should read: The reverse stock split will be implemented when the market opens on Monday, November 7, 2016 .

Guided Therapeutics Receives Order For 7 LuViva® Advanced Cervical Scans And 4,000 Disposable Cervical Guides For Indonesia

Guided Therapeutics Receives Order For 7 LuViva® Advanced Cervical Scans And 4,000 Disposable Cervical Guides For Indonesia

Guided Therapeutics, Inc. (OTCQB: GTHP), developer of the LuViva® Advanced Cervical Scan, a non-invasive device used to detect cervical disease instantly and at the point of care, today announced it has received an...

Guided Therapeutics Reports Second Quarter 2016 Financial Results; Year To Date Revenue Up 71% Over Same Period Last Year

Guided Therapeutics Reports Second Quarter 2016 Financial Results; Year To Date Revenue Up 71% Over Same Period Last Year

Guided Therapeutics, Inc. (OTCQB: GTHP), developer of the LuViva® Advanced Cervical Scan, a non-invasive device used to detect cervical disease instantly and at the point of care, today announced financial results for...

Guided Therapeutics Ships Additional LuViva® Advanced Cervical Scan Systems And Disposables To Bangladesh

Guided Therapeutics Ships Additional LuViva® Advanced Cervical Scan Systems And Disposables To Bangladesh

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, today announced that it shipped four additional LuViva® Advanced Cervical Scan...

Guided Therapeutics Sells First LuViva® Advanced Cervical Scan To Russia

Guided Therapeutics Sells First LuViva® Advanced Cervical Scan To Russia

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, today announced that it has sold the first LuViva® Advanced Cervical Scan to its...

Guided Therapeutics Ships Five LuViva® Advanced Cervical Scans To Nairobi County, Kenya For Cervical Cancer Screening Program

Guided Therapeutics Ships Five LuViva® Advanced Cervical Scans To Nairobi County, Kenya For Cervical Cancer Screening Program

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, today announced that it has shipped five LuViva® Advanced Cervical Scans to...

Guided Therapeutics Expanding Use Of The LuViva® Advanced Cervical Scan In Bulgaria

Guided Therapeutics Expanding Use Of The LuViva® Advanced Cervical Scan In Bulgaria

Guided Therapeutics, Inc. (OTCQB: GTHP) announced today that it has received an order and payment for a third LuViva® Advanced Cervical Scan and 500 single-use disposable cervical guides for Bulgaria.

Guided Therapeutics Enters Into LuViva® Advanced Cervical Scan License Agreement For China

Guided Therapeutics Enters Into LuViva® Advanced Cervical Scan License Agreement For China

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it has reached a licensing agreement with Shenghuo Medical, LLC,...

Guided Therapeutics Reports Record First Quarter 2016 Results

Guided Therapeutics Reports Record First Quarter 2016 Results

Guided Therapeutics, Inc. (OTCQB:GTHP) today announced its operating results for the first quarter ended March 31, 2016.

Guided Therapeutics Ships First LuViva® Advanced Cervical Scan For The Dominican Republic

Guided Therapeutics Ships First LuViva® Advanced Cervical Scan For The Dominican Republic

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today shipment of the first LuViva ® Advanced Cervical Scan for the...

Guided Therapeutics Issues Letter To Shareholders

Guided Therapeutics Issues Letter To Shareholders

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, today released the following letter to shareholders.

Guided Therapeutics Announces 1:100 Reverse Stock Split

Guided Therapeutics Announces 1:100 Reverse Stock Split

Guided Therapeutics, Inc. (OTCQB: GTHP) today announced a one-for-one hundred (1:100) reverse split of its issued and outstanding common stock.

Guided Therapeutics Expands LuViva® Advanced Cervical Scan Distribution In Latin America

Guided Therapeutics Expands LuViva® Advanced Cervical Scan Distribution In Latin America

Guided Therapeutics, Inc. (OTCQB:GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that the company continues to expand in international markets with the...

Guided Therapeutics' To Sell Five Additional LuViva® Advanced Cervical Scans To Nairobi County, Kenya For Cervical Cancer Screening Program

Guided Therapeutics' To Sell Five Additional LuViva® Advanced Cervical Scans To Nairobi County, Kenya For Cervical Cancer Screening Program

Guided Therapeutics, Inc. (OTCQB: GTHP), a maker of a rapid and painless testing platform based on its patented biophotonic technology, today announced that Nairobi County Health Services Sector has agreed to purchase an...

Guided Therapeutics Expects Significant Sales Growth In 2016

Guided Therapeutics Expects Significant Sales Growth In 2016

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that the company expects to achieve a second consecutive quarter of...

Guided Therapeutics Achieves Record Quarterly Revenue

Guided Therapeutics Achieves Record Quarterly Revenue

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today fourth quarter sales revenue for the LuViva® Advanced Cervical...

Guided Therapeutics Ships First Order Of 10,000 LuViva® Advanced Cervical Scan Disposables For $14 Million Turkish Ministry Of Health Order

Guided Therapeutics Ships First Order Of 10,000 LuViva® Advanced Cervical Scan Disposables For $14 Million Turkish Ministry Of Health Order

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it shipped the first 10,000 LuViva® Advanced Cervical Scan...

Guided Therapeutics And FDA Review Team Agree On Path Forward For LuViva® Advanced Cervical Scan PMA Application

Guided Therapeutics And FDA Review Team Agree On Path Forward For LuViva® Advanced Cervical Scan PMA Application

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today it believes it has reached a general agreement with the U.

Guided Therapeutics To Present At LD Micro "Main Event" Investor Conference

Guided Therapeutics To Present At LD Micro "Main Event" Investor Conference

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it will be presenting at the LD Micro "Main Event" Investor...

Guided Therapeutics Reports Third Quarter 2015 Financial Results

Guided Therapeutics Reports Third Quarter 2015 Financial Results

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today that it reported third quarter financial results for the period ended...